BVBeatriz Cristina Weidle Vuaden

Beatriz Cristina Weidle Vuaden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Beatriz Cristina Weidle Vuaden has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differential Effects of Cannabidiol and Cannabigerol on Cognition, Neuroinflammation, and Blood–Brain Barrier Integrity in a Rat Model of Iron Overload

    by Layza Kowalski, Anna C. M. Colucci, Juliana B. dos Santos, Beatriz W. Vuaden, Alice L. Herlinger, Jaime E. C. Hallak, Antônio W. Zuardi, José A. S. Crippa, Maria N. M. de Lima, Nadja Schröder

    Iron is an essential micronutrient for brain development, participating in mitochondrial respiration, myelination, and neurotransmitter synthesis. However, previous studies have demonstrated that excessive iron during early postnatal life induces oxidative reactions, leading to mitochondrial dysfunction and synaptic failure. These alterations compromise energy metabolism and neuronal integrity, contributing to long-lasting cognitive dysfunction and increased brain vulnerability later in life. This study evaluated the effects of cannabidiol (CBD) and cannabigerol (CBG) on behavioral, neuroinflammatory, and blood-brain barrier (BBB) outcomes in rats exposed to early-life iron overload. Male Wistar rats received iron carbonyl (30 mg/kg, intragastrically) from postnatal day 12 to 14. At three months of age, they were treated intraperitoneally with CBD, CBG (both at 10 mg/kg), or vehicle for 21 days. Cognitive performance was assessed in the open field and object recognition tasks. We examined hippocampal levels of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), as proinflammatory markers, and occludin, a protein known to regulate BBB permeability. Iron-exposed animals showed impaired recognition memory, with elevated TNF-α and IL-1β, while CBD reversed memory deficits and reduced IL-1β in iron-treated animals, without affecting TNF-α. CBG restored memory, decreased IL-1β in both iron-treated and controls, and increased TNF-α in controls. Also, iron overload reduced occludin expression in vehicle-treated rats which was reversed by both CBD and CBG. These findings highlight inflammation and BBB disruption as mediators of iron-induced cognitive dysfunction and show that both phytocannabinoids act through distinct but complementary mechanisms, supporting their therapeutic potential in neuroinflammation linked to iron overload.


  • Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in rats

    by Fernanda Borsatto Caruso, Maria Paula Arakaki Severo, Anna Clara Machado Colucci, Beatriz Cristina Weidle Vuaden, Layza Kowalski, Patrícia Schonhofen, Felipe Schroeder Franke, Fernanda Bastos de Mello, Fernanda da Silva Rodrigues, Renata Padilha Guedes, et al.

    The aim of this study was to investigate the effects of cannabidiol (CBD) on memory deficits induced by ovariectomy and to directly compare its effects with those of hormone therapy, in order to better understand potential shared mechanisms related to menopause‐associated cognitive decline, with a particular focus on the endocannabinoid system. Three‐month‐old female Wistar rats were randomly assigned to four experimental groups: SHAM‐Veh (Vehicle), OVX‐Veh, OVX‐E2 (estradiol), and OVX‐CBD. Animals underwent either bilateral ovariectomy or sham surgery. Following a three‐week recovery period, rats received daily subcutaneous injections of CBD (10 mg/kg), estradiol (10 μg/kg), or vehicle for 21 consecutive days. Behavioral assessments included object recognition and fear‐motivated memory tests. Twenty‐four hours after the final treatment, animals were euthanized for neurochemical and molecular analyses. Levels of the endocannabinoids anandamide (AEA) and 2‐arachidonoylglycerol (2‐AG) were measured using high‐performance liquid chromatography. Gene expression of cannabinoid receptors CB1 and CB2, as well as enzymes involved in the synthesis and degradation of endocannabinoids (NAPE‐PLD, DAGL‐A, FAAH, and MGLL), was evaluated in the hippocampus by RT‐qPCR. The results demonstrated that CBD treatment produced memory improvements in the object recognition task comparable to those observed with estradiol. Ovariectomy‐induced impairments in fear‐motivated memory were completely reversed by both CBD and estradiol treatments. Additionally, CBD reduced the expression of FAAH and MGLL, resulting in increased hippocampal levels of AEA and 2‐AG, effects similar to those observed with hormone therapy. Estradiol also increased NAPE‐PLD expression, contributing to elevated AEA levels. Overall, the findings suggest that CBD exerts a protective effect on memory comparable to standard estrogen therapy, supporting its therapeutic potential for menopause‐related cognitive impairments.